Remedy Meds
4 known investors
Remedy Meds offers personalized medical weight loss treatment using compounded GLP-1 medications (semaglutide and tirzepatide) paired with clinician-led care and support delivered directly to patients. The service targets individuals seeking prescription-based weight loss solutions with ongoing medical supervision and community support.
Digital HealthHealthtech
Investors · 4
Competitors · 4
by search overlapRo482 shared keywordsRo is an online healthcare platform that connects patients with licensed providers and delivers prescription treatments, including GLP-1 medications for weight loss, ED treatments, and other health goals. The direct-to-consumer telehealth service is fully online and serves individual patients in the United States.
Lemonaid444 shared keywordsLemonaid Health is a national telehealth company offering online medical assessments, U.S.-based clinical review, and home delivery of prescription medicines, including GLP-1 weight loss treatments. It serves consumers across all 50 states, with a medical team of physicians, pharmacists, nurse practitioners, and registered nurses.
Found343 shared keywordsFound offers clinically-led, personalized weight care that combines evidence-based medical treatment (including provider-prescribed medications) with support to help members lose weight and improve their health. It serves individuals seeking accessible, judgment-free weight management.
Alloy325 shared keywordsAlloy is a telehealth service that connects women in midlife and menopause with board-certified, menopause-trained doctors for treatments including hormone therapy, GLP-1 weight care, skincare, sexual health, hair and gut health. It offers online intake, ongoing messaging with physicians, and cash-pay/FSA-HSA-eligible prescription products.
Companies competing with Remedy Meds for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Remedy Meds do?
- Remedy Meds offers personalized medical weight loss treatment using compounded GLP-1 medications (semaglutide and tirzepatide) paired with clinician-led care and support delivered directly to patients. The service targets individuals seeking prescription-based weight loss solutions with ongoing medical supervision and community support.
- Who are Remedy Meds's investors?
- Remedy Meds's investors include 137 Ventures, Dynamism Capital, HealthQuest Capital, Maveron.